Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James A Wiseman

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Ageing Research Reviews|December 12, 2024
From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathiesJames A Wiseman, Kreesan Reddy, Birger Victor Dieriks
Brain : a Journal of Neurology|February 5, 2025
Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophyJames A Wiseman, Glenda M Halliday, Birger Victor Dieriks
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|August 30, 2021
Cell Type-Specific Nuclei Markers: The Need for Human Brain Research to Go NuclearJames A Wiseman, Mike Dragunow, Thomas I-H Park
Translational Neurodegeneration|February 7, 2025
Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophyJames A Wiseman, Clinton P Turner, Richard L M Faull, et al.
Translational Neurodegeneration|December 26, 2024
N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson's diseaseJames A Wiseman, YuHong Fu, Richard L M Faull, et al.
NPJ Parkinson'S Disease|January 3, 2024
Aggregate-prone brain regions in Parkinson's disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibilityJames A Wiseman, Helen C Murray, Richard L M F Faull, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2023
PSA-NCAM Regulatory Gene Expression Changes in the Alzheimer's Disease Entorhinal Cortex Revealed with Multiplexed in situ HybridizationBlake Highet, James A Wiseman, Hannah Mein, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Ageing Research Reviews|December 12, 2024
From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathiesJames A Wiseman, Kreesan Reddy, Birger Victor Dieriks
Brain : a Journal of Neurology|February 5, 2025
Neuronal α-synuclein toxicity is the key driver of neurodegeneration in multiple system atrophyJames A Wiseman, Glenda M Halliday, Birger Victor Dieriks
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|August 30, 2021
Cell Type-Specific Nuclei Markers: The Need for Human Brain Research to Go NuclearJames A Wiseman, Mike Dragunow, Thomas I-H Park
Translational Neurodegeneration|February 7, 2025
Refining α-synuclein seed amplification assays to distinguish Parkinson's disease from multiple system atrophyJames A Wiseman, Clinton P Turner, Richard L M Faull, et al.
Translational Neurodegeneration|December 26, 2024
N-terminus α-synuclein detection reveals new and more diverse aggregate morphologies in multiple system atrophy and Parkinson's diseaseJames A Wiseman, YuHong Fu, Richard L M Faull, et al.
NPJ Parkinson'S Disease|January 3, 2024
Aggregate-prone brain regions in Parkinson's disease are rich in unique N-terminus α-synuclein conformers with high proteolysis susceptibilityJames A Wiseman, Helen C Murray, Richard L M F Faull, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2023
PSA-NCAM Regulatory Gene Expression Changes in the Alzheimer's Disease Entorhinal Cortex Revealed with Multiplexed in situ HybridizationBlake Highet, James A Wiseman, Hannah Mein, et al.
Pageof 1